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'\1 ." Starz! ef al evaluate the place of cadaveric pancreas t ran'plan t, in diabet· 
\g "\ ics with and without kidney transplants. A remarkable five of elght pan-
creas grafts were functioning 2.5-19 months posttransplant. It is proposed 
that the spleen be engrafted with the pancreas both to improve graft blood 
supply and to induce tolerance. With the most active transplant groups in 
the United States now exploring pancreas allografting, we may anticipate 
a "go" or "no go" answer to their utility within the next three years. 
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ABSTRACT 
Eight patients have undergone whole pancreas transplantation 
for the treatment of diabetes mellitus at this center. Six of the recip-
ients had previously been given cadaver kidneys, one was given a 
kidney from the pancreas donor, and the other patient received a 
pancreas alone. One of the pancreatic grafts failed from thrombo-
sis, but the other seven provided prolonged function. Five of the 
grafts are still functioning from 2.5 to 19 months later, a sixth 
functioned perfectly for 14 months and then failed, necessitating 
return to insulin therapy, and a seventh is undergoing rejection 
after 4 months, for which monoclonal antilymphocyte globulin 
(ALG) therapy is being given. Exocrine drainage of whole-organ 
pancreatic grafts has been achieved conveniently by retaining a 
graft duodenal bubble through which exocrine pancreatic secre-
tions are directed into the intestinal tract. A case has been made-
for transplanting the spleen with the pancreas for the purpose of 
improving the graft blood supply and with the possible objective of 
inducing graft acceptance. 
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INTRODUCTION 
The pancreas transplantations performed since the first attempt by 
Kelly and Lillihei, et a1. in 19661 have been recorded by Sutherland and 
Kendall in an international registry.2 By the end of June, 1984, a total of 
nearly 500 cases had been contributed from more than 50 institutions at 
a rapidly increasing accrual rate. The results from these efforts have 
remained discouraging. Even in 1983 and 1984, only about one-third of 
the transplants, including segmental grafts from relative donors, have 
functioned for as long as a year. During these recent times, the one-year 
patient mortality has remained at the disturbingly high level of almost 
25 percent.2 
The graft failures, patient morbidity, and patient mortality have been 
due partly to technical imperfections in the procedure itself and partly to 
the limitations of conventional immunosuppression. Consequently, this 
group has re-examined the technical aspects of pancreas transplantation. 
Mter preliminary work in dogs,3 a procedure was developed that has 
yielded encouraging results in human recipients treated with cyclo-
sporine and steroids.4 
METHODS 
Surgical Technique 
The entire pancreas is removed along with the duodenum, proximal 
jejunum, and spleen. The arterial blood supply of the composite graft is 
based upon a Carrel patch of the anterior aortic wall, which includes the 
origin of the celiac axis and the superior mesenteric artery. The outflow 
from the graft is through the portal vein. The specimen is cooled with a 
chilled preservation (Collins) fluid. The arterial Carrel patch is anasto-
mosed to the recipient common or external iliac artery, either intraperito-
neally or in the left extraperitoneal space (Fig. 1). If necessary, the graft 
can be placed on th.e right side, although this requires rotation of the 
specimen (Fig. 2), as described elsewhere.4 
The spleen usually is left with the graft. Graft splenectomy has been 
performed in only one of our 8 cases before transplantation. The jejunum, 
and as much proximal and distal duodenum as possible, is excised, leav-
ing a "bubble" of duodenum into which the ampulla of Vater empties 
(Fig. 1). The proximal and distal ends of the bubble are closed and the 
duodenum is anastomosed to the side of the proximal jejunum. 
Tissue Typing 
The pancreas grafts were from heart-beating cadaver donors. In 7 of the 
8 cases, the ABO groups of the donor and recipient were the same. In the 
eighth, the donor was blood type 0 and the recipient was A. 
- ......... j 
A Resurgence of Interest in Whole Pancreas Transplantation 
A ... V. 
Fig. 1. Completed pancreatic transplantation. Note 
inclusion of spleen and removal of as much duodenum as 
possible. 
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Tissue matching was random, and because of this, there were no 
matches of the 4 possible antigens at the A and B histocompatibility loci 
in 6 of the patients. There was a one-antigen match in one case and a 2-
antigen match in the other. 
At the DR locus, 6 of the 8 recipients had the 3,4 combination of anti-
gens which has been associated with diabetes mellitus.5 The 2 other 
patients had either a DR3 or 4 antigen, but not both. Two of the donors 
had a DR4, and no donor had both. In 2 of the 8 cases, a single DR antigen 
was matched. No DR antigens were matched in the other six. 
Case Material 
All 8 of the recipients were Type I diabetics. Their ages were 24-42 
years (mean 31.2) and they had been insulin-dependent for 18-29 years. 
Seven were men and one was a woman. 
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Fig. 2. Pancreatico·duodeno-splenic graft used in the 
first 2 patients. The intestinal segment developed mucosal 
slough and a protein-losing enteropathy which caused 
intractible diarrhea. At reoperation, the small bowel was 
trimmed to the proportions shown in Figure 1. 
Six of the 8 pancreas recipients had been given a cadaver kidney from a 
few weeks to 8.5 months previously. A seventh patient was provided with 
a kidney from the same donor as the pancreas and one patient was given 
a pancreas alone. 
The 6 patients who had been given cadaveric kidneys at an earlier time 
were already being treated with cyclosporine and steroids. At the time of 
the pancreatic transplantation, this immunosuppression was intensified, 
as described in detail elsewhere.4 Patients undergoing pancreas trans-
plantation alone, or in combination with kidney transplantation from the 
same donor, were treated by the techniques previously developed for 
cadaveric kidney6 and hepatic7 transplantation. Intravenous cyclosporine 
was given postoperatively until it was ascertained by pharmacologic 
A Resurgence of Interest in Whole Pancreas Transplantation 505 
monitoring that the oral dosage was being well tolerated. Subsequently, 
the cyclosporine and steroid doses were gradually reduced. Cyclosporine 
doses were monitored by frequent measurements of the venous blood 
concentration of the drug. 
RESULTS 
Mortality 
All eight of the pancreas recipients are still alive after follow-ups of 
2.5-19 months. The patient who received only a pancreas had several 
serious bouts of insulin induced hypoglycemia preoperatively, leaving 
him with central neurologic deficits. Five weeks postoperatively he had a 
respiratory arrest. Despite prompt resuscitation, he has been left with 
further neurologic invalidism and is hospital-bound. The other 7 patients 
live at home. 
Pancreatic Graft Function 
One pancreatic graft was lost to vascular thrombosis within a few hours 
and was removed. The other 7 pancreases functioned promptly and per-
mitted the patients to live completely free of insulin. One graft failed 14 
months after transplantation, a few weeks after completely normal glu-
cose tolerance tests had been obtained during testing in the Clinical 
Research Center. Insulin therapy was resumed, although at about half 
the dosage previously required. 
The other 6 patients remained insulin-free 2.5-19 months postopera-
tively. The patient who received a pancreas alone 4 months ago had a 
rejection after 3.5 postoperative months, necessitating a return to insulin 
therapy. The rejection is being treated with a course of monoclonal OKT3 
antibody, with at least partial restoration of pancreatic function. 
The other 5 patients are insulin-free after 2.5, 4.5, 6, 11, and 19 months. 
All five have had normal glucose tolerance tests and have undergone 
significant social and/or vocational rehabilitation, 
The patients who had had previous cadaveric kidney transplantation (6 
cases) or a concomitant kidney transplantation (one case) have stable 
function of their renal grafts. 
Complications of the Spleen r"' r 
a\Alf.!:,!.!.!!./ 
The spleen was transplanted as part of the graft in 7 of iAe 6 cases. 
Splenectomy was performed in 3 of these 7 recipients at 6.5, 18, and 20 
days postoperatively. In the patient with type A blood who had been given '\ 
ct~ 
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a type 0 spleen, the spleen was shown to have produced anti·A isoag· 
glutins in sufficient quantities to cause severe hemolysis of the recipient's 
red blood cells.4 This complication was relieved promptly by splenectomy. 
The other splenectomies (after 18 and 20 days) were because of thrombo· 
cytopenia and leukopenia (one case each). In the 3 patients who under· 
went graft splenectomy, the procedure was extremely easy. The lateral 
end of the wounds were reopened and each splenectomy was performed 
within a few minutes and with virtually no blood loss. 
Four patients still have their grafted spleens in place after 2.5, 4.5, and 
19 months. 
Complications of the Duodenum and Jejunum 
The first 2 patients developed intractible diarrhea several weeks post· 
operatively, as well as vague, cramping abdominal pain. In these 
patients, a long jejunal segment had been left for anastomoses to the 
recipient jejunum (Fig. 2). In one patient, the graft jejunum was detached 
and brought to the skin as a jejunostomy, where it was shown to elaborate 
from one to 3 liters of protein-rich, plasma-like fluid. 4 It was concluded 
that the jejunum was the site of a protein-losing enteropathy.4 Eventu-
ally, the jejunum and most of the duodenum were removed, leaving a 
duodenal bubble such as that shown in Figure 1. 
In patient 5, in whom the intent was to perform the duodenal bubble 
procedure, too much of the C-Ioop of the duodenum was left in place (Fig. 
3). One month postoperatively, the patient was readmitted with uncon-
trollable diarrhea. The C-Ioop was trimmed back to the small bubble (Fig. 
1) and the patient recovered with no further complaints. 
Neuropathy, Blindness, and Gangrene 
The patient whose graft thrombosed acutely, and the recipient with 
pre~xisting and subsequent neurologic invalidism have had no benefit 
from their transplantations. The other six have had variable reversal of 
peripheral neuropathy and evidence of reversal of the autonomic neurop-
athy that is common in end-stage diabetes.7.9 They have redeveloped the 
capacity to adjust their heart rates to need, have had restoration of 
impaired gastrointestinal tract motility, and have had improved bladder 
function. The patient whose graft functioned for 14 months before failing 
resumed sexual function 6 months postoperatively, after more than 5 
years of impotence. 
All of the patients had had problems with retinopathy before transplan-
tation, with an invariable history of multiple laser treatments. One 
patient was legally blind and another was completely blind in one eye. 
The preexisting situation was stabilized in each instance, but not 
reversed. 
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Fig. 3. A homograft C-loop (marked) which was responsi-
ble for diarrhea and which required resection. 
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One patient with bilateral Charcot ankle joints, complete distal anes-
thesia from his knees, and peripheral vascular insufficiency has under-
gone bilateral below-knee amputations. There was a partial reversal of 
the neuropathy, but this was incomplete and occurred too late to permit 
salvage of the legs. 
DISCUSSION 
The subtle but cumulatively dramatic benefits of successful pancreatic 
transplantation have been illustrated by the 6 patients who achieved 
long-term graft function in this experience. During the insulin-free state, 
the reversal of neuropathy and the stabilization of small-vessel disease 
and eye complaints were striking. The transplantation procedures neces--
sary to achieve these effects were relatively simple and, except for throm-
bosis of the graft blood supply in one case, devoid of acute complications. 
The inclusion of the extrapancreatic organs was nevertheless responsi-
ble for morbidity and in these studies, and the liabilities specific to both 
the spleen and the small intestine were defined. The spleen was responsi-
ble for isolated examples of hemolytic anemia, thrombocytopenia, and 
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leukopenia, complications of splenic transplantation which were recog-
nized 2 decades ago in dogs10 and in humans_ 12 
In spite of these complications, this center has continued to include the 
spleen with total pancreatic grafts, with the proviso that there be donor-
recipient ABO identity. One justification has been the provision of a high-
flow blood supply to the graft. The other justification has been that 
mitigation or delay of the rejection of the kidney,IO skin 14 and pancreas16 
has been described in such diverse species as the dog, rat, and guinea pig 
when the spleen is transplanted as a companion organ_ 
In contrast, this center has eliminated as much intestine as possible 
from all pancreatic grafts after the second one in this series, leaving only 
enough duodenum at the level of the ampulla of Vater for a side-to-side 
anastomosis to recipient jejunum (Fig. 1). Even in one of the later 
patients, in whom an excessive amount of the duodenal C-Ioop was 
retained (Fig_ 3), severe diarrhea occurred which could not be relieved 
without excision of the superfluous duodenal tissue. 
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